These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812 [TBL] [Abstract][Full Text] [Related]
24. Annual Mammographic Screening Reduces the Risk of Interval or Higher Stage Invasive Breast Cancers Among Postmenopausal Women in the Ontario Breast Screening Program. Blackmore KM; Chiarelli AM; Mirea L; Mittmann N; Muradali D; Rabeneck L; Done SJ Can Assoc Radiol J; 2022 Aug; 73(3):524-534. PubMed ID: 35068172 [No Abstract] [Full Text] [Related]
25. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia. Randall D; Morrell S; Taylor R; Hung WT Cancer Causes Control; 2009 Jul; 20(5):559-66. PubMed ID: 19015941 [TBL] [Abstract][Full Text] [Related]
26. Breast cancer in the elderly patient: early detection with mammography. Wilson TE; Helvie MA; August DA Radiology; 1994 Jan; 190(1):203-7. PubMed ID: 8259405 [TBL] [Abstract][Full Text] [Related]
27. The association between the pre-diagnosis mammography screening interval and advanced breast cancer. Goel A; Littenberg B; Burack RC Breast Cancer Res Treat; 2007 May; 102(3):339-45. PubMed ID: 16927175 [TBL] [Abstract][Full Text] [Related]
28. Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50. Winch CJ; Sherman KA; Boyages J Breast Cancer Res Treat; 2015 Jan; 149(1):211-21. PubMed ID: 25476499 [TBL] [Abstract][Full Text] [Related]
29. Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis? Kremer ME; Downs-Holmes C; Novak RD; Lyons JA; Silverman P; Pham RM; Plecha DM AJR Am J Roentgenol; 2012 May; 198(5):1218-22. PubMed ID: 22528917 [TBL] [Abstract][Full Text] [Related]
30. Annual vs Biennial Screening: Diagnostic Accuracy Among Concurrent Cohorts Within the Ontario Breast Screening Program. Chiarelli AM; Blackmore KM; Mirea L; Done SJ; Majpruz V; Weerasinghe A; Rabeneck L; Muradali D J Natl Cancer Inst; 2020 Apr; 112(4):400-409. PubMed ID: 31233138 [TBL] [Abstract][Full Text] [Related]
31. Patients' opinion of mammography screening services: immediate results versus delayed results due to interpretation by two observers. Hulka CA; Slanetz PJ; Halpern EF; Hall DA; McCarthy KA; Moore R; Boutin S; Kopans DB AJR Am J Roentgenol; 1997 Apr; 168(4):1085-9. PubMed ID: 9124120 [TBL] [Abstract][Full Text] [Related]
32. Neglecting to screen women between 40 and 49 years old with mammography: what is the impact on treatment morbidity and potential risk reduction? Plecha D; Salem N; Kremer M; Pham R; Downs-Holmes C; Sattar A; Lyons J AJR Am J Roentgenol; 2014 Feb; 202(2):282-8. PubMed ID: 24450666 [TBL] [Abstract][Full Text] [Related]
33. Survival advantage differences by age. Evaluation of the extended follow-up of the Breast Cancer Detection Demonstration Project. Byrne C; Smart CR; Chu KC; Hartmann WH Cancer; 1994 Jul; 74(1 Suppl):301-10. PubMed ID: 8004601 [TBL] [Abstract][Full Text] [Related]
34. Mammographic Screening at Age 40 or 45? What Difference Does It Make? The Potential Impact of American Cancer Society Mammography Screening Guidelines. Fancher CE; Scott A; Allen A; Dale P Am Surg; 2017 Aug; 83(8):847-849. PubMed ID: 28822389 [TBL] [Abstract][Full Text] [Related]
35. Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations. Ikeda DM; Andersson I; Wattsgård C; Janzon L; Linell F AJR Am J Roentgenol; 1992 Aug; 159(2):287-94. PubMed ID: 1632342 [TBL] [Abstract][Full Text] [Related]
36. Breast Cancer Risk and Screening Mammography Frequency Among Multiethnic Women. Zhang J; McGuinness JE; He X; Jones T; Silverman T; Guzman A; May BL; Kukafka R; Crew KD Am J Prev Med; 2023 Jan; 64(1):51-60. PubMed ID: 36137818 [TBL] [Abstract][Full Text] [Related]
37. Breast carcinoma with basal phenotype: mammographic findings. Luck AA; Evans AJ; James JJ; Rakha EA; Paish EC; Green AR; Ellis IO AJR Am J Roentgenol; 2008 Aug; 191(2):346-51. PubMed ID: 18647900 [TBL] [Abstract][Full Text] [Related]
39. Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women. Mittmann N; Blackmore KM; Seung SJ; Diong C; Done SJ; Chiarelli AM Curr Oncol; 2023 Sep; 30(9):8550-8562. PubMed ID: 37754535 [TBL] [Abstract][Full Text] [Related]
40. Comparison of Screened and Nonscreened Breast Cancer Patients in Relation to Age: A 2-Institution Study. Barco I; Chabrera C; García Font M; Gimenez N; Fraile M; Lain JM; Piqueras M; Vidal MC; Torras M; González S; Pessarrodona A; Barco J; Cassadó J; García Fernández A Clin Breast Cancer; 2015 Dec; 15(6):482-9. PubMed ID: 25986958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]